Glaxo drugs aid recovery
Article Abstract:
Glaxo Wellcome will announce promising results from its Aids drugs at the 11th International Conference on Aids to be held in Canada in Jul 1996. The company's 1592 Aids treatment also appears to be performing well and this news has helped boost the company's share price. Glaxo's share price has underperformed in relation to other pharmaceutical companies in the 12 months to June 1996 due to concern over the end of the patent for Zantac. Analysts argue that Glaxo's new products should offset the impact of the end of the patent.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
NicOx
Article Abstract:
French drug development firm NicOx's unique technique offers the firm strong growth potential, and its shares are rated a good buy. NicOx's patented chemical technique offers a low-risk way of improving all drug classes.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Drugs can be bad for your wealth
Article Abstract:
Antisoma stocks have fallen in value after news of a trial leading to doubts over the safety of the company's Theragyn product. The implications for investors are examined.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic: